NCT00807794 - A Safety Clinical Trial of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft Rejection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 1997

Primary Completion Date

November 30, 1997

Study Completion Date

January 31, 1998

Conditions

Kidney Diseases

Interventions

DRUG

MEDI-507

0.012 mg/kg dose given twice between 60 to 72 hours apart

DRUG

MEDI-507

0.06 mg/kg dose given twice between 60 to 72 hours apart

DRUG

MEDI-507

0.12 mg/kg dose given twice between 60 to 72 hours apart

DRUG

MEDI-507

0.24 mg/kg dose given twice between 60 to 72 hours apart (supplemental)

DRUG

MEDI-507

0.50 mg/kg dose given twice between 60 to 72 hours apart (supplemental)

Trial Locations (4)

University of Virginia, Charlottesville

Indiana University, Bloomington

San Antonio Community Hospital, San Antonio

Yale University School of Medicine, New Haven